The treatment of patients with anticardiolipin syndrome has substantially evolved since they were discovered to be clinically important in the mid-1980s.
Patsientide raviks kardiolipiinivastased sündroom on oluliselt muutunud, sest need olid avastanud, et olla kliiniliselt oluline 1980ndate keskpaigast.